Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women

Su Zhang,1 Ke Xu,2 Su-Xiao Liu,3 Xiao-Lan Ye,1 Ping Huang,1 Hong-Juan Jiang1 1Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 2Laborator...

Full description

Bibliographic Details
Main Authors: Zhang S, Xu K, Liu SX, Ye XL, Huang P, Jiang HJ
Format: Article
Language:English
Published: Dove Medical Press 2023-06-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/retrospective-analysis-of-azithromycin-resistant-ureaplasma-urealyticu-peer-reviewed-fulltext-article-IDR
_version_ 1797809999827697664
author Zhang S
Xu K
Liu SX
Ye XL
Huang P
Jiang HJ
author_facet Zhang S
Xu K
Liu SX
Ye XL
Huang P
Jiang HJ
author_sort Zhang S
collection DOAJ
description Su Zhang,1 Ke Xu,2 Su-Xiao Liu,3 Xiao-Lan Ye,1 Ping Huang,1 Hong-Juan Jiang1 1Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 2Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 3Center for Reproductive Medicine, Department of Obstetrics, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Hong-Juan Jiang, Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China, Tel +86 571 85893143, Fax +86 571 87666666, Email tigergirl@126.comPurpose: Ureaplasma urealyticum and Mycoplasma hominis began to show resistance to azithromycin, a macrolide antibiotic commonly used in pregnancy. Unfortunately, there are few effective and safe drugs in the clinic for genital mycoplasmas in pregnant women. In the present study, we investigated the prevalence of azithromycin-resistant U. urealyticum and M. hominis infections in pregnant women. The secondary research objects were possible influencing factors and consequences of insensitive Mycoplasma infection.Patients and methods: A retrospective analysis was carried out in pregnant women who underwent cervical Mycoplasma culture between October 2020 and October 2021 at a large general hospital in eastern China. The sociological characteristics and clinical information of these women were collected and analyzed.Results: A total of 375 pregnant women were enrolled, and 402 cultured mycoplasma specimens were collected. Overall, 186 (49.60%) patients tested positive cervical Mycoplasma infection, and 37 (9.87%) had infections caused by azithromycin-resistant Mycoplasma. In total, 39 mycoplasma samples were insensitive to azithromycin in vitro, also showing extremely high resistance to erythromycin, roxithromycin, and clarithromycin. Azithromycin was the only antibiotic used in women with Mycoplasma cervical infection, regardless of azithromycin resistance in vitro. Statistical results showed that azithromycin-resistant cervical Mycoplasma infection in pregnant women was unrelated to age, body mass index (BMI), gestational age, number of embryos, and assisted reproductive technology (ART) use, but led to a significantly increased incidence of adverse pregnancy outcomes (spontaneous abortion (SA), preterm birth (PTB), preterm prelabor rupture of membranes (PPROM), and stillbirth).Conclusion: Azithromycin-resistant U. urealyticum and M. hominis cervical infections are relatively common during pregnancy, and can increase the risk of adverse pregnancy outcomes; however, there is currently a lack of safe and effective drug treatments. Herein, we show that azithromycin-resistant mycoplasma infection requires timely intervention.Keywords: azithromycin resistance, Ureaplasma urealyticum, Mycoplasma hominis, pregnant women
first_indexed 2024-03-13T07:01:28Z
format Article
id doaj.art-a8a0c6de8e4a4729ad714d0e10a1de1b
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-03-13T07:01:28Z
publishDate 2023-06-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-a8a0c6de8e4a4729ad714d0e10a1de1b2023-06-06T19:22:44ZengDove Medical PressInfection and Drug Resistance1178-69732023-06-01Volume 163541354984207Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant WomenZhang SXu KLiu SXYe XLHuang PJiang HJSu Zhang,1 Ke Xu,2 Su-Xiao Liu,3 Xiao-Lan Ye,1 Ping Huang,1 Hong-Juan Jiang1 1Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 2Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 3Center for Reproductive Medicine, Department of Obstetrics, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Hong-Juan Jiang, Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China, Tel +86 571 85893143, Fax +86 571 87666666, Email tigergirl@126.comPurpose: Ureaplasma urealyticum and Mycoplasma hominis began to show resistance to azithromycin, a macrolide antibiotic commonly used in pregnancy. Unfortunately, there are few effective and safe drugs in the clinic for genital mycoplasmas in pregnant women. In the present study, we investigated the prevalence of azithromycin-resistant U. urealyticum and M. hominis infections in pregnant women. The secondary research objects were possible influencing factors and consequences of insensitive Mycoplasma infection.Patients and methods: A retrospective analysis was carried out in pregnant women who underwent cervical Mycoplasma culture between October 2020 and October 2021 at a large general hospital in eastern China. The sociological characteristics and clinical information of these women were collected and analyzed.Results: A total of 375 pregnant women were enrolled, and 402 cultured mycoplasma specimens were collected. Overall, 186 (49.60%) patients tested positive cervical Mycoplasma infection, and 37 (9.87%) had infections caused by azithromycin-resistant Mycoplasma. In total, 39 mycoplasma samples were insensitive to azithromycin in vitro, also showing extremely high resistance to erythromycin, roxithromycin, and clarithromycin. Azithromycin was the only antibiotic used in women with Mycoplasma cervical infection, regardless of azithromycin resistance in vitro. Statistical results showed that azithromycin-resistant cervical Mycoplasma infection in pregnant women was unrelated to age, body mass index (BMI), gestational age, number of embryos, and assisted reproductive technology (ART) use, but led to a significantly increased incidence of adverse pregnancy outcomes (spontaneous abortion (SA), preterm birth (PTB), preterm prelabor rupture of membranes (PPROM), and stillbirth).Conclusion: Azithromycin-resistant U. urealyticum and M. hominis cervical infections are relatively common during pregnancy, and can increase the risk of adverse pregnancy outcomes; however, there is currently a lack of safe and effective drug treatments. Herein, we show that azithromycin-resistant mycoplasma infection requires timely intervention.Keywords: azithromycin resistance, Ureaplasma urealyticum, Mycoplasma hominis, pregnant womenhttps://www.dovepress.com/retrospective-analysis-of-azithromycin-resistant-ureaplasma-urealyticu-peer-reviewed-fulltext-article-IDRazithromycin resistanceureaplasma urealyticummycoplasma hominispregnant women
spellingShingle Zhang S
Xu K
Liu SX
Ye XL
Huang P
Jiang HJ
Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women
Infection and Drug Resistance
azithromycin resistance
ureaplasma urealyticum
mycoplasma hominis
pregnant women
title Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women
title_full Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women
title_fullStr Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women
title_full_unstemmed Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women
title_short Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women
title_sort retrospective analysis of azithromycin resistant ureaplasma urealyticum and mycoplasma hominis cervical infection among pregnant women
topic azithromycin resistance
ureaplasma urealyticum
mycoplasma hominis
pregnant women
url https://www.dovepress.com/retrospective-analysis-of-azithromycin-resistant-ureaplasma-urealyticu-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT zhangs retrospectiveanalysisofazithromycinresistantureaplasmaurealyticumandmycoplasmahominiscervicalinfectionamongpregnantwomen
AT xuk retrospectiveanalysisofazithromycinresistantureaplasmaurealyticumandmycoplasmahominiscervicalinfectionamongpregnantwomen
AT liusx retrospectiveanalysisofazithromycinresistantureaplasmaurealyticumandmycoplasmahominiscervicalinfectionamongpregnantwomen
AT yexl retrospectiveanalysisofazithromycinresistantureaplasmaurealyticumandmycoplasmahominiscervicalinfectionamongpregnantwomen
AT huangp retrospectiveanalysisofazithromycinresistantureaplasmaurealyticumandmycoplasmahominiscervicalinfectionamongpregnantwomen
AT jianghj retrospectiveanalysisofazithromycinresistantureaplasmaurealyticumandmycoplasmahominiscervicalinfectionamongpregnantwomen